176P Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332)

Autor: Hauke, J., Ernst, C., Fasching, P.A., Jackisch, C., Seither, F., Klare, P., Rhiem, K.E., Schmatloch, S., Huober, J., Stefek, A., Seiler, S., Uleer, C., Doering, G., Schneeweiss, A., Denkert, C., Untch, M., Blohmer, J-U., Schmutzler, R.K., Loibl, S., Hahnen, E.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S313-S313
Databáze: ScienceDirect